Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 60 (Supplement 2), S129-S134
Those with severe kidney disease should also use berberine cautiously and under medical supervision, as specific guidance is limited given berberine's status as a supplement rather than a regulated pharmaceutical
Chen S, Zhou M, Sun J, Guo A, Fernando RL, Chen Y et al (2019) DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
If that lighter, natural approach is what you are after, the key is choosing a well-made supplement and setting realistic expectations
Incidence Rates and Clinical Trial Data on GLP-1Associated Headaches Major clinical trials for semaglutide, tirzepatide, and other GLP-1 agonists document headache occurrence across different patient populations, doses, and indications
(Find more information here.) Whats Ahead in 2025